1 Min Read
May 8 (Reuters) - Claris Lifesciences Ltd
* Says approved sale of shares of Otsuka Pharmaceutical India to Otsuka Pharmaceutical Factory for $20 million Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.